Skip to main content
. Author manuscript; available in PMC: 2012 Nov 4.
Published in final edited form as: J Proteome Res. 2011 Oct 18;10(11):5232–5241. doi: 10.1021/pr200800w

Table 1.

Clinical characteristics of HNSCC patients

Patient
No		 Sex/Age Specimen type Diagnosis Grade TNM Stage
1 M/58 Tongue NAT/Tumor G2 T1N0M0 I
2 M/62 Tongue NAT/Tumor G2 T3N0M0 III
3 F/64 Tongue NAT/Tumor G3 T4aN2bM0 IVA
4 M/79 Tongue NAT/Tumor G3 T3N0M0 III
5 F/72 Oral cavity NAT/Tumor G2 T2N0M0 II
6 F/39 Oral cavity NAT/Tumor G2 T3N1M0 IVA
7 M/57 Oral cavity NAT/Tumor G1 T4N0M0 IVA
8 F/88 Lip NAT/Tumor G2 T3N0M0 III
9 F/83 Lip NAT/Tumor G3 T3N0M0 III
10 M/59 Larynx NAT/Tumor G2 T3N0M0 III
11 M/50 Larynx NAT/Tumor G3 T3N0M0 III
12 M/70 Larynx NAT/Tumor G2 T3N0M0 III
13 M/59 Larynx NAT/Tumor G2 T3N0M0 III
14 M/67 Larynx NAT/Tumor G1-G2 T1N2bM0 IVA
15 M/67 Larynx NAT/Tumor G2 T3N1M0 III
16 M/63 Larynx NAT/Tumor G2 T4aN1M0 IVA
Lymph Node Metastases
17 M/57 Larynx NAT/Tumor G2 T2N2bM0 IVA
Lymph Node Metastases
18 M/53 Larynx NAT/Tumor G2 T2N2bM0 IVA
Lymph Node Metastases
19 M/59 Lymph Node Metastases G2 T3N1M0 III
20 M/48 Lymph Node Metastases G1 T2N1M0 III
21 M/58 Lymph Node Metastases N/A Recurrent N/A
22 F/61 Lymph Node Metastases G1 T2N2bM0 IVA